Colgate-Palmolive Stock Forecast, Price & News

Colgate-Palmolive's stock was trading at $68.90 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, CL shares have increased by 13.5% and is now trading at $78.21.
View which stocks have been most impacted by COVID-19.

14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Colgate-Palmolive in the last twelve months. There are currently 3 sell ratings, 5 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" Colgate-Palmolive stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CL, but not buy additional shares or sell existing shares.
View analyst ratings for Colgate-Palmolive or view MarketBeat's top 5 stock picks.

Wall Street analysts have given Colgate-Palmolive a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Colgate-Palmolive wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

195 employees have rated Colgate-Palmolive CEO Noel Wallace on Glassdoor.com. Noel Wallace has an approval rating of 95% among Colgate-Palmolive's employees. This puts Noel Wallace in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

Colgate-Palmolive is scheduled to release its next quarterly earnings announcement on Friday, January 29th 2021.
View our earnings forecast for Colgate-Palmolive.

Colgate-Palmolive will be holding an earnings conference call on Friday, January 29th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Colgate-Palmolive (NYSE:CL) posted its earnings results on Wednesday, November, 4th. The company reported $0.79 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $0.70 by $0.09. The firm had revenue of $4.15 billion for the quarter, compared to analysts' expectations of $4 billion. Colgate-Palmolive had a trailing twelve-month return on equity of 383.88% and a net margin of 16.65%. Colgate-Palmolive's quarterly revenue was up 5.7% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.71 EPS.
View Colgate-Palmolive's earnings history.

Colgate-Palmolive announced a quarterly dividend on Thursday, January 14th. Shareholders of record on Monday, January 25th will be paid a dividend of $0.44 per share on Tuesday, February 16th. This represents a $1.76 annualized dividend and a dividend yield of 2.25%. The ex-dividend date of this dividend is Friday, January 22nd.
View Colgate-Palmolive's dividend history.

Colgate-Palmolive pays an annual dividend of $1.76 per share and currently has a dividend yield of 2.24%. Colgate-Palmolive has been increasing its dividend for 59 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio of Colgate-Palmolive is 62.19%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Colgate-Palmolive will have a dividend payout ratio of 53.99% next year. This indicates that Colgate-Palmolive will be able to sustain or increase its dividend.
View Colgate-Palmolive's dividend history.

14 equities research analysts have issued twelve-month price objectives for Colgate-Palmolive's stock. Their forecasts range from $67.00 to $90.00. On average, they expect Colgate-Palmolive's share price to reach $79.85 in the next year. This suggests a possible upside of 2.1% from the stock's current price.
View analysts' price targets for Colgate-Palmolive or view Wall Street analyst' top-rated stocks.

Some companies that are related to Colgate-Palmolive include The Procter & Gamble (PG), Kimberly-Clark (KMB), The Clorox (CLX), Church & Dwight (CHD), WD-40 (WDFC), Spectrum Brands (SPB), Central Garden & Pet (CENTA), Oil-Dri Co. of America (ODC) and Orchids Paper Products (TIS).
View all of CL's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Colgate-Palmolive investors own include Johnson & Johnson (JNJ), The Procter & Gamble (PG), AT&T (T), AbbVie (ABBV), PepsiCo (PEP), Verizon Communications (VZ), The Coca-Cola (KO), Intel (INTC), McDonald's (MCD) and The Walt Disney (DIS).

Colgate-Palmolive trades on the New York Stock Exchange (NYSE) under the ticker symbol "CL."

Colgate-Palmolive's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Sarasin & Partners LLP (0.38%), Confluence Investment Management LLC (0.17%), New York State Teachers Retirement System (0.13%), Boston Trust Walden Corp (0.06%), LGT Capital Partners LTD. (0.06%) and Welch Group LLC (0.05%). Company insiders that own Colgate-Palmolive stock include Daniel B Marsili, Dennis J Hickey, Helene D Gayle, Henning I Jakobsen, Ian M Cook, Jennifer Daniels, John J Huston, John T Cahill, John W Kooyman, Justin Skala, Michael B Polk, Noel R Wallace, Panagiotis Tsourapas, Patricia Verduin, Philip G Shotts, Prabha Parameswaran, Sally Massey and Stephen I Sadove.
View institutional ownership trends for Colgate-Palmolive.

CL stock was sold by a variety of institutional investors in the last quarter, including LGT Capital Partners LTD., Sarasin & Partners LLP, New York State Teachers Retirement System, Hexavest Inc., Confluence Investment Management LLC, Avantax Advisory Services Inc., Loring Wolcott & Coolidge Fiduciary Advisors LLP MA, and Pacer Advisors Inc.. Company insiders that have sold Colgate-Palmolive company stock in the last year include Daniel B Marsili, Helene D Gayle, Henning I Jakobsen, Ian M Cook, Jennifer Daniels, John J Huston, John T Cahill, John W Kooyman, Michael B Polk, Noel R Wallace, Panagiotis Tsourapas, Patricia Verduin, Philip G Shotts, and Sally Massey.
View insider buying and selling activity for Colgate-Palmolive or view top insider-selling stocks.

CL stock was bought by a variety of institutional investors in the last quarter, including KAMES CAPITAL plc, Kestra Advisory Services LLC, Janney Montgomery Scott LLC, Pendal Group Limited, Sound Financial Strategies Group LLC, Bellecapital International Ltd., Eidelman Virant Capital, and Vigilant Capital Management LLC.
View insider buying and selling activity for Colgate-Palmolive or or view top insider-buying stocks.

Shares of CL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of CL stock can currently be purchased for approximately $78.21.

Colgate-Palmolive has a market capitalization of $67.04 billion and generates $15.69 billion in revenue each year. The company earns $2.37 billion in net income (profit) each year or $2.83 on an earnings per share basis. Colgate-Palmolive employs 34,300 workers across the globe.

The official website for Colgate-Palmolive is www.colgatepalmolive.com.

Colgate-Palmolive's mailing address is 300 PARK AVE, NEW YORK NY, 10022. The company can be reached via phone at 212-310-2000 or via email at [email protected]